In agreement with results obtained in TNF-treated microglia and macrophages, QPCR analysis revealed that TNF treatment induced downregulation of Parkin mRNA in primary dopaminergic neuroblastoma cells (Figure 4A). The gene discussed is PRKN; the disease is neuroblastoma.